Carol Sheridan

1.5k total citations · 1 hit paper
15 papers, 1.1k citations indexed

About

Carol Sheridan is a scholar working on Oncology, Immunology and Infectious Diseases. According to data from OpenAlex, Carol Sheridan has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Immunology and 2 papers in Infectious Diseases. Recurrent topics in Carol Sheridan's work include Neutropenia and Cancer Infections (3 papers), Cancer Cells and Metastasis (2 papers) and Herpesvirus Infections and Treatments (2 papers). Carol Sheridan is often cited by papers focused on Neutropenia and Cancer Infections (3 papers), Cancer Cells and Metastasis (2 papers) and Herpesvirus Infections and Treatments (2 papers). Carol Sheridan collaborates with scholars based in United States, Australia and Russia. Carol Sheridan's co-authors include Harikrishna Nakshatri, Sanjana Mehrotra, Sunil Badve, Robert J. Goulet, Poornima Bhat‐Nakshatri, Hiromitsu Kishimoto, Robyn K. Fuchs, Charles H. Turner, Miral R. Sadaria and Christopher J. Sweeney and has published in prestigious journals such as PLoS ONE, American Journal of Obstetrics and Gynecology and American Journal of Physiology-Endocrinology and Metabolism.

In The Last Decade

Carol Sheridan

14 papers receiving 1.1k citations

Hit Papers

CD44+/CD24-breast cancer cells exhibit enhanced invasive ... 2006 2026 2012 2019 2006 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CD44+/CD24-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis
    2006 798 citations Carol Sheridan, Hiromitsu Kishimoto et al. Breast Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carol Sheridan United States 8 645 556 311 114 102 15 1.1k
Jun-Lin Guan United States 8 565 0.9× 660 1.2× 203 0.7× 144 1.3× 272 2.7× 8 1.2k
Xiancheng Chen China 21 249 0.4× 582 1.0× 186 0.6× 50 0.4× 158 1.5× 46 1.0k
Bruna Scaggiante Italy 24 238 0.4× 873 1.6× 359 1.2× 44 0.4× 104 1.0× 66 1.3k
Cheng Chang United States 19 319 0.5× 762 1.4× 268 0.9× 184 1.6× 111 1.1× 33 1.1k
Mei Zhao China 26 294 0.5× 1.1k 2.0× 595 1.9× 51 0.4× 151 1.5× 62 1.7k
Nobutomo Miwa Japan 14 281 0.4× 1.3k 2.3× 187 0.6× 130 1.1× 46 0.5× 19 1.7k
Caroline Saucier Canada 21 412 0.6× 751 1.4× 184 0.6× 132 1.2× 320 3.1× 37 1.4k
Genbao Shao China 22 235 0.4× 871 1.6× 256 0.8× 111 1.0× 64 0.6× 60 1.3k
Bruce E. Linebaugh United States 15 248 0.4× 421 0.8× 334 1.1× 137 1.2× 60 0.6× 23 850
Yongliang Liu China 15 190 0.3× 554 1.0× 145 0.5× 126 1.1× 184 1.8× 49 1.1k

Countries citing papers authored by Carol Sheridan

Since Specialization
Citations

This map shows the geographic impact of Carol Sheridan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Sheridan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Sheridan more than expected).

Fields of papers citing papers by Carol Sheridan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol Sheridan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Sheridan. The network helps show where Carol Sheridan may publish in the future.

Co-authorship network of co-authors of Carol Sheridan

This figure shows the co-authorship network connecting the top 25 collaborators of Carol Sheridan. A scholar is included among the top collaborators of Carol Sheridan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Sheridan. Carol Sheridan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Chen, Victor, Lauren Allen, Kelsie Cowman, et al.. (2021). Antimicrobial Stewardship-Driven Monoclonal Antibody Treatment Program for COVID-19 Patients in the Bronx, New York. Antimicrobial Stewardship & Healthcare Epidemiology. 1(S1). s57–s57.
2.
Bartash, Rachel, Kelsie Cowman, Wendy Szymczak, et al.. (2020). Multidisciplinary Tool Kit for Febrile Neutropenia: Stewardship Guidelines,Staphylococcus aureusEpidemiology, and Antibiotic Use Ratios. JCO Oncology Practice. 16(7). e563–e572. 2 indexed citations
3.
Sheridan, Carol. (2013). The Science of Patient Safety: Implications for Oncology Nursing Practice. Clinical journal of oncology nursing. 17(6). 601–603. 1 indexed citations
4.
Petrini, Karin, Frances Crabbe, Carol Sheridan, & Frank Pollick. (2011). The Music of Your Emotions: Neural Substrates Involved in Detection of Emotional Correspondence between Auditory and Visual Music Actions. PLoS ONE. 6(4). e19165–e19165. 30 indexed citations
5.
Stewart, Meredith, et al.. (2007). Sequence analysis of Jembrana disease virus strains reveals a genetically stable lentivirus. Virus Research. 126(1-2). 233–244. 11 indexed citations
6.
Sheridan, Carol, Hiromitsu Kishimoto, Robyn K. Fuchs, et al.. (2006). CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Publisher. 5 indexed citations
7.
Sheridan, Carol, Hiromitsu Kishimoto, Robyn K. Fuchs, et al.. (2006). CD44+/CD24-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Research. 8(5). R59–R59. 798 indexed citations breakdown →
8.
Sheridan, Carol, Miral R. Sadaria, Poornima Bhat‐Nakshatri, et al.. (2006). Negative regulation of MHC class II gene expression by CXCR4. Experimental Hematology. 34(8). 1085–1092. 16 indexed citations
9.
Bell, Lauren N., Jennifer L. Ward, Mikako Degawa‐Yamauchi, et al.. (2006). Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity. American Journal of Physiology-Endocrinology and Metabolism. 291(4). E843–E848. 94 indexed citations
10.
Sweeney, Christopher J., Sanjana Mehrotra, Miral R. Sadaria, et al.. (2005). The sesquiterpene lactone parthenolide in combination with docetaxel reduces metastasis and improves survival in a xenograft model of breast cancer. Molecular Cancer Therapeutics. 4(6). 1004–1012. 131 indexed citations
11.
Stewart, Meredith, Carol Sheridan, William Ditcham, et al.. (2004). Recombinant Jembrana disease virus gag proteins identify several different antigenic domains but do not facilitate serological differentiation of JDV and nonpathogenic bovine lentiviruses. Journal of Virological Methods. 124(1-2). 135–142. 12 indexed citations
12.
Sheridan, Carol. (1996). Multiple myeloma. Seminars in Oncology Nursing. 12(1). 59–69. 5 indexed citations
13.
Toner, Guy C., Janice Gabrilove, Michael S. Gordon, et al.. (1994). Phase I Trial of Intravenous and Intraperitoneal Administration of Granulocyte-Macrophage Colony-Stimulting Factor. Journal of Immunotherapy. 15(1). 59–66. 10 indexed citations
14.
Ciobanu, Niculae, Carolyn D. Runowicz, Peter H. Wiernik, et al.. (1989). CA 125 levels in patients with ovarian carcinoma undergoing autologous bone marrow transplantation. American Journal of Obstetrics and Gynecology. 160(2). 354–355. 1 indexed citations
15.
D’Olimpio, James, Michael H. Miller, Carol Sheridan, et al.. (1987). A Comparative Trial of Moxalactam Plus Ticarcillin and Clavulanic Acid or Piperacillin as Empiric Antibiotic Therapy for Febrile Cancer Patients. The Journal of Clinical Pharmacology. 27(9). 673–677. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun-Lin Guan Breakdown of academic impact, for papers by Xiancheng Chen Breakdown of academic impact, for papers by Bruna Scaggiante Breakdown of academic impact, for papers by Cheng Chang Breakdown of academic impact, for papers by Mei Zhao Breakdown of academic impact, for papers by Nobutomo Miwa Breakdown of academic impact, for papers by Caroline Saucier Breakdown of academic impact, for papers by Genbao Shao Breakdown of academic impact, for papers by Bruce E. Linebaugh Breakdown of academic impact, for papers by Yongliang Liu
Rankless by CCL
2026